Karanewsky et al., "(Phosphinyloxy)acyl amino acids inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogues of (S)-1-[6-amino-2[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline" J. Med. Chem. (1990) 33(5):1459-1469. |
Smith et al., "Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines" J. Med. Chem. (1988) 31(4):875-885. |
Krapcho et al., "Angiotensin converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines" J. Med. Chem. (1988) 31(6):1148-1160. |
Hock et al., "Hoe 140 a new potent and long acting bradykinin antagonist: in vitro studies" Br. J. Pharmacol. (1991) 102:769-744. |
Wirth et al., "Hoe 140 a new potent and long acting bradykinin antagonist: in vivo studies" Br. J. Pharmacol. (1991) 102:774-777. |
Pongracic et al., "A competitive kinin receptor antagonist, [DArg.sup.0, Hyp.sup.3, DPhe.sup.7 ]-bradykinin, does not affect the response to nasal provocation with bradykinin" Br. J. Pharmacol. (1991) 31:287-294. |
Higgins et al., "A study of the efficacy of the bradykinin antagonist NPC567 in rhinovirus infections in human volunteers" Chemical Abstracts (1991) 114:220805d. |
Soler et al., "A bradykinin antagonist modifies antigen-induced airway hyper-responsiveness and airway inflammation in allergic sheep" Am. Rev. Respir. Dis. (1989) A327. |
Stewart, John M., "Hydroxyproline analogs of bradykinin" J. Med. Chem. (1974) 17(5):537-539. |
Stewart, John M., "Chemistry and biologic activity of peptides related to bradykinin" Handbook of Experimental Pharmacol. (1979) vol. XXV Supp, Springer-Verlag Berlin Heidelberg NY. |
Vavrek et al., "Smooth muscle selectivity in bradykinin analogs with multiple D-amino acid substitutions", Dept. of Biochem., University of Colorado School of Medicine, Denver, Colorado. |
Rifo et al., "Bradykinin receptor antagonists used to characterize the heterogeneity of bradykinin-induced responses in rat vas deferens" Eur. J. Pharmacol. (1987) 142:305-312. |
Zeitlin et al., "Mobilization of tissue kallikrein in inflammatory disease of the colon" Wolfson Labs, Gastrointestinal Unit, West General Hospital and Dept. of Clinical Surgery, Univ. of Edinburgh (1972) pp. 113-138. |
Suzuki et al., "Synthesis of every kind of peptide fragments of bradykinin" Chem. Pharm. Bull. (1969) 17:1671-1678. |
Dray et al. "Bradykinin and inflammatory pain" TINS (1993) 16(3):99-104. |
Perkins et al., "Antinociceptive activity of the bradykinin B.sub.1 and B.sub.2 receptor antagonists des-Arg.sup.9, [Leu.sup.8 ]-BK and HOE 140, in two models of persistent hyperalgesia in the rat" Pain (1993) 53:191-197. |
Zabrocki et al., "Conformational Mimicry. 3. Synthesis and incorporation of 1,5-disubstituted tetrazole dipeptide analogues into peptides with preservation of chiral integrity: bradykinin" J. Org. Chem. (1992) 57(1):202-209. |
Hodges et al. (eds.) Peptides, Chemistry, Structures and Biology: Proceedings of the 13th American Peptide Symposium Jun. 20-25, 1993 (ESCOM: Leiden, 1994), pp. 381-383. |
Kyle et al., "A proposed model of bradykinin bound to the rat B.sub.2 receptor and its utility for drug design" J. Med. Chem. (1994) 37(9):1347-1354. |
Abstracts of Papers, Part 1: 208th American Chemical Society National Meeting Aug. 21-25, 1994 190. |
Kyle et al., "NMR and computational evidence that high-affinity bradykinin receptor antagonists adopt C-terminal .beta.-turns" J. Med. Chem. (1993) 36(10):1450-1460. |
Hodges et al. (eds.) Peptides, Chemistry, Structure and Biology: Proceedings of the 13th American Peptide Symposium Jun. 20-25, 1993 (ESCOM: Leiden, 1994), pp. 449-451. |